Interestana
Home/News/California, US Clash Over Hospice Fraud, Patient Coverage
MedPage Today3 min read

By Interestana AI Editorial — AI-drafted, human-overseen. How we report

California, US Clash Over Hospice Fraud, Patient Coverage

California, US Clash Over Hospice Fraud, Patient Coverage

California and the federal government are engaged in a significant legal battle concerning widespread hospice fraud, a conflict that has direct consequences for patient access to vital end-of-life care and has resulted in the loss of coverage for numerous individuals. The dispute centers on allegations of fraudulent practices within the hospice industry, which have prompted federal intervention and oversight, leading to a clash with California's state-level regulatory and healthcare systems. This situation has created uncertainty and disruption for patients who rely on hospice services, as well as for the providers themselves.

At the heart of the issue are concerns that fraudulent entities have infiltrated the hospice care system, exploiting vulnerable patients and defrauding Medicare. These fraudulent operations often provide substandard or unnecessary services, or bill for services not rendered, thereby draining public healthcare resources. In response to these widespread allegations, federal agencies have taken steps to investigate and prosecute those involved in hospice fraud. However, these federal actions have sometimes led to the suspension or termination of Medicare payments to hospice providers, which in turn can result in the abrupt loss of coverage for patients who were receiving legitimate care from those same providers. This has created a scenario where genuine patients are caught in the crossfire of enforcement actions targeting bad actors.

California, as a state with a large population and a significant number of healthcare providers, has been particularly affected by these federal actions. State officials have expressed concerns that the broad strokes of federal enforcement are unfairly penalizing legitimate hospice providers and disrupting care for patients who have been properly enrolled and are receiving appropriate services. The state argues that its own regulatory mechanisms are sufficient to address fraud within its borders and that federal overreach is causing undue harm. This disagreement has escalated into legal challenges, with California seeking to assert its authority and protect its residents from the fallout of federal investigations and sanctions. The legal proceedings aim to clarify the division of authority between state and federal entities in regulating hospice care and combating fraud.

The consequences for patients have been severe. Many individuals, like Linda Henry, a 71-year-old retiree who believed she was in good health and only sought occasional checkups, discovered in 2024 that their hospice coverage had been terminated due to federal actions against their providers. This abrupt loss of coverage can leave patients and their families in a precarious position, struggling to find alternative care options during a critical and sensitive time. The situation highlights the complex interplay between healthcare regulation, fraud prevention, and patient welfare, underscoring the need for coordinated efforts between federal and state authorities to ensure that legitimate care is not compromised in the pursuit of justice against fraudulent operators.

Original source — read the full reporting at the publisher:

Read on MedPage Today

Get the weekly AI digest

AI news + new model releases, weekly. Drafted by our agents, reviewed by humans.

Read next